AngioDynamics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AngioDynamics and other ETFs, options, and stocks.

About ANGO

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. 

CEO
James Christopher Clemmer
CEOJames Christopher Clemmer
Employees
675
Employees675
Headquarters
Latham, New York
HeadquartersLatham, New York
Founded
1988
Founded1988
Employees
675
Employees675

ANGO Key Statistics

Market cap
405.58M
Market cap405.58M
Price-Earnings ratio
-12.95
Price-Earnings ratio-12.95
Dividend yield
Dividend yield
Average volume
626.34K
Average volume626.34K
High today
$9.80
High today$9.80
Low today
$9.80
Low today$9.80
Open price
$10.32
Open price$10.32
Volume
1.15K
Volume1.15K
52 Week high
$13.99
52 Week high$13.99
52 Week low
$8.36
52 Week low$8.36

Stock Snapshot

As of today, AngioDynamics(ANGO) shares are valued at $9.80. The company's market cap stands at 405.58M, with a P/E ratio of -12.95.

On 2026-04-07, AngioDynamics(ANGO) stock moved within a range of $9.80 to $9.80. With shares now at $9.80, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 1.15K, compared to an average daily volume of 626.34K.

The stock's 52-week range extends from a low of $8.36 to a high of $13.99.

The stock's 52-week range extends from a low of $8.36 to a high of $13.99.

ANGO News

TipRanks 2d
AngioDynamics Earnings Call Highlights Med Tech Momentum

Angiodynamics, Inc. ((ANGO)) has held its Q3 earnings call. Read on for the main highlights of the call. Easter Sale - 70% Off TipRanks Unlock hedge fund-level...

TipRanks 5d
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Nasdaq 5d
AngioDynamics Reports Q3 Loss, Tops Revenue Estimates

AngioDynamics (ANGO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.0...

AngioDynamics Reports Q3 Loss, Tops Revenue Estimates

More ANGO News

Nasdaq 5d
AngioDynamics Q3 Pro Forma Adj. EBITDA Rises; Lifts FY26 Guidance

(RTTNews) - AngioDynamics, Inc. (ANGO) reported a third quarter GAAP net loss of $8.1 million, or a loss per share of $0.19 compared to a loss of $4.4 million o...

AngioDynamics Q3 Pro Forma Adj. EBITDA Rises; Lifts FY26 Guidance

People also own

Based on the portfolios of people who own ANGO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.